Highlights of the European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

Follow Highlights of the European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Share on
Copy link to clipboard

This audio podcast reports on some of the most important new MS research presented at the ECTRIMS annual meeting, held October 13-16, 2010, in Gothenburg, Sweden. Listen as James D. Bowen, MD, talks about new findings that enhance understanding of MS path


    • Oct 28, 2010 LATEST EPISODE
    • infrequent NEW EPISODES
    • 9m AVG DURATION
    • 6 EPISODES


    Search for episodes from Highlights of the European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting with a specific topic:

    Latest episodes from Highlights of the European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

    Update on Current MS Therapies - Part 2

    Play Episode Listen Later Oct 28, 2010 8:40


    Dr. Lublin discusses new data on other existing MS therapies: interferon beta, natalizumab, mitoxantrone, and fampridine.

    Update on Current MS Therapies - Part 1

    Play Episode Listen Later Oct 28, 2010 6:05


    Dr. Lublin discusses new data on existing MS therapies: glatiramer acetate and fingolimod, as well as the addition of statins to interferon beta-1a.

    Update on Emerging MS Therapies - Part 2

    Play Episode Listen Later Oct 28, 2010 9:46


    Dr. Lublin describes the latest data presented at ECTRIMS on additional emerging MS therapies (firategrast, cladribine, alemtuzumab, daclizumab, laquinimod, BG00012).

    Update on Emerging MS Therapies - Part 1

    Play Episode Listen Later Oct 28, 2010 8:46


    Dr. Lublin describes the latest data on some of the emerging MS therapies now in late-stage clinical trials (teriflunomide, ocrelizumab and ofatumumab), presented on ECTRIMS.

    Testing, Neuroregeneration, and Cognition

    Play Episode Listen Later Oct 28, 2010 12:43


    In this next section of the podcast, Dr. Bowen looks at the extent to which new data at ECTRIMS answer some important questions about MS testing, neuroregeneration, and cognitive impairment.

    MS Pathophysiology: Immunology and Genetics

    Play Episode Listen Later Oct 28, 2010 12:03


    Dr. Bowen discusses ECTRIMS presentations on lesser-known components of the immune system that contribute to the disease. He also discusses data on genetic causes of MS.

    Claim Highlights of the European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel